Therapeutics

Small Molecule

  • Study completed / Planned end date
  • Planned end date unavailable
  • Study aborted
Small Molecule 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
AGB101
Phase 2
ALZT-OP1
Phase 3
AZD1446
Phase 2
AZD3293
Phase 2/3, Phase 3
Acitretin
Phase 2
Anavex 2-73
Phase 2
Avagacestat
Phase 2
Azeliragon
Phase 3
Brexpiprazole
Phase 3
CHF 5074
Phase 2
CNP520
Phase 2, Phase 2/3
Dexpramipexole
Phase 2
ELND005
Phase 2
EVP-0962
Phase 2
Elenbecestat
Phase 2
Encenicline
Phase 2, Phase 3
FRM-0334
Phase 2
Idalopirdine
Phase 2, Phase 3
Intepirdine
Phase 2, Phase 3
JNJ-54861911
Phase 2, Phase 2/3
LMTM
Phase 2, Phase 3
MK-7622
Phase 2
Masitinib
Phase 2, Phase 3
NIC5-15
Phase 2
Neflamapomid
Phase 2
Nelonicline
Phase 2
ORM-12741
Phase 2
PF-05212377
Phase 2
Pioglitazone
Phase 2, Phase 3
Piromelatine
Phase 2
Riluzole
Phase 2
SUVN-502
Phase 2
Saracatinib
Phase 2
Thalidomide
Phase 2/3
Verubecestat
Phase 1, Phase 2/3, Phase 3